Scarlet Therapeutics Limited (13536278) is a private limited with share capital incorporated on 28/07/2021 (4 years old) and registered in bristol, BS20JZ. The company operates under SIC code 72110 and is classified as Micro.
Scarlet therapeutics is developing a unique platform that generates novel red blood cell-based therapeutics to potentially treat a wide range of diseases. initially targeted at the rare metabolic diseases, hyperammonemia and hyperoxaluria, this approach could also be used more broadly to target othe...
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:24-06-2024
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:24-06-2024
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:15-03-2024
Withdrawal Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:03-10-2023
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:03-10-2023
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:03-10-2023
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:02-10-2023
Second Filing Of Confirmation Statement With Made Up Date
Category:Confirmation Statement
Date:29-09-2023
Capital Allotment Shares
Category:Capital
Date:27-09-2023
Capital Allotment Shares
Category:Capital
Date:27-09-2023
Confirmation Statement
Category:Confirmation Statement
Date:08-08-2023
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:04-08-2023
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:04-08-2023
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:24-04-2023
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:16-01-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:21-12-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:21-12-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:21-12-2022
Resolution
Category:Resolution
Date:22-08-2022
Memorandum Articles
Category:Incorporation
Date:22-08-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:17-08-2022
Capital Allotment Shares
Category:Capital
Date:17-08-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:02-08-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:01-08-2022
Resolution
Category:Resolution
Date:20-07-2022
Capital Alter Shares Subdivision
Category:Capital
Date:20-07-2022
Capital Allotment Shares
Category:Capital
Date:15-07-2022
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:14-07-2022
Incorporation Company
Category:Incorporation
Date:28-07-2021
Innovate Grants
2
This company received a grant of £332036.02 for Univercell: An Engineered Red Blood Cell Line To Unlock A New, Universal Therapeutic Modality. The project started on 01/09/2023 and ended on 28/02/2025.
This company received a grant of £587680.0 for Bioengineered Reticulocytes Containing Metabolic Enzymes To Treat Hyperammonemia And Hyperoxaluria. The project started on 01/05/2024 and ended on 31/01/2026.